Free Trial

LifeMD (LFMD) Stock Price, News & Analysis

LifeMD logo
$6.46 +0.05 (+0.78%)
Closing price 04:00 PM Eastern
Extended Trading
$6.43 -0.03 (-0.46%)
As of 05:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About LifeMD Stock (NASDAQ:LFMD)

Key Stats

Today's Range
$6.32
$6.53
50-Day Range
$6.11
$15.06
52-Week Range
$3.99
$15.84
Volume
976,637 shs
Average Volume
1.66 million shs
Market Capitalization
$306.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.17
Consensus Rating
Buy

Company Overview

LifeMD Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
51st Percentile Overall Score

LFMD MarketRank™: 

LifeMD scored higher than 51% of companies evaluated by MarketBeat, and ranked 559th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LifeMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    LifeMD has only been the subject of 4 research reports in the past 90 days.

  • Read more about LifeMD's stock forecast and price target.
  • Earnings Growth

    Earnings for LifeMD are expected to grow in the coming year, from ($0.56) to $0.12 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LifeMD is -30.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LifeMD is -30.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    LifeMD has a P/B Ratio of 646.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about LifeMD's valuation and earnings.
  • Percentage of Shares Shorted

    11.68% of the float of LifeMD has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeMD has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in LifeMD has recently increased by 2.07%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    LifeMD does not currently pay a dividend.

  • Dividend Growth

    LifeMD does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.68% of the float of LifeMD has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeMD has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in LifeMD has recently increased by 2.07%, indicating that investor sentiment is decreasing.
  • News Sentiment

    LifeMD has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 24 news articles for LifeMD this week, compared to 3 articles on an average week.
  • Search Interest

    14 people have searched for LFMD on MarketBeat in the last 30 days. This is an increase of 180% compared to the previous 30 days.
  • MarketBeat Follows

    4 people have added LifeMD to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, LifeMD insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,564,550.00 in company stock.

  • Percentage Held by Insiders

    18.40% of the stock of LifeMD is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 35.52% of the stock of LifeMD is held by institutions.

  • Read more about LifeMD's insider trading history.
Receive LFMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LFMD Stock News Headlines

Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days.tc pixel
See More Headlines

LFMD Stock Analysis - Frequently Asked Questions

LifeMD's stock was trading at $4.95 on January 1st, 2025. Since then, LFMD shares have increased by 30.5% and is now trading at $6.46.

LifeMD, Inc. (NASDAQ:LFMD) posted its quarterly earnings data on Tuesday, May, 6th. The company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.05. The business earned $65.70 million during the quarter, compared to the consensus estimate of $62.47 million.
Read the conference call transcript
.

Top institutional investors of LifeMD include Connor Clark & Lunn Investment Management Ltd. (2.04%), Geode Capital Management LLC (2.04%), Jump Financial LLC (1.09%) and Arrowstreet Capital Limited Partnership (0.92%). Insiders that own company stock include Justin Schreiber, Bertrand Velge, Marc David Benathen, Nicholas P Alvarez, Jessica Friedeman, Stefan Galluppi and Eric Harold Yecies.
View institutional ownership trends
.

Shares of LFMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeMD investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), e.l.f. Beauty (ELF), Adobe (ADBE) and Jabil (JBL).

Company Calendar

Last Earnings
5/06/2025
Today
8/28/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:LFMD
CIK
948320
Fax
N/A
Employees
230
Year Founded
N/A

Price Target and Rating

High Price Target
$18.00
Low Price Target
$7.00
Potential Upside/Downside
+103.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.88 million
Net Margins
-2.41%
Pretax Margin
-1.83%
Return on Equity
N/A
Return on Assets
-8.11%

Debt

Debt-to-Equity Ratio
9.21
Current Ratio
0.77
Quick Ratio
0.72

Sales & Book Value

Annual Sales
$212.45 million
Price / Sales
1.44
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.01 per share
Price / Book
646.30

Miscellaneous

Outstanding Shares
47,420,000
Free Float
38,692,000
Market Cap
$306.48 million
Optionable
Optionable
Beta
1.72
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:LFMD) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners